Plantar pustules in a psoriasis patient during the guselkumab therapy

Código QR

Plantar pustules in a psoriasis patient during the guselkumab therapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Shinsuke Nakazawa, Tetsuya Honda
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/746b57a944ac4beea263fa6e8e1c604b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hypertrophic lichenoid dermatitis during pembrolizumab treatment
por: Ryoma Honda, et al.
Publicado: (2021)

Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
por: Hideaki Uchida, et al.
Publicado: (2021)

Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
por: Susumu Ichiyama, et al.
Publicado: (2021)

Myocarditis in a patient with anti‐OJ and Th/To autoantibody‐positive overlap syndrome
por: Shuhei Yonamine, et al.
Publicado: (2021)

Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021)

A case of bullous pemphigoid after a long‐term administration of anti‐PD‐1 antibodies in a patient with non‐small‐cell lung cancer
por: Emi Yokoyama, et al.
Publicado: (2021)

Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period
por: Chan Y, et al.
Publicado: (2021)

Anti‐MJ/NXP‐2 antibody‐positive adult‐onset dermatomyositis with lichen myxedematosus and endometrial carcinoma
por: Kimiko Nakajima, et al.
Publicado: (2021)

A case of Stevens–Johnson syndrome‐like eruption suggesting clinical importance of body temperature and serum levels of receptor‐interacting kinase 3
por: Ryo Nishiyori, et al.
Publicado: (2021)

A case of leukoderma probably caused by a soap containing neem oil
por: Eriko Takayama, et al.
Publicado: (2021)

Long‐term remission of severe livedoid vasculopathy treated with a short course of intravenous immunoglobulin
por: Shunsuke Takahagi, et al.
Publicado: (2021)

Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
por: Akihiro Matsubara, et al.
Publicado: (2021)

A pediatric case of cellulitis caused by Stenotrophomonas maltophilia with subcutaneous microvascular thrombosis and diffuse hemorrhage
por: Emi Inoue, et al.
Publicado: (2021)

Maculopapular erythema caused by previously used chemotherapy drugs after nivolumab treatment for malignant mesothelioma
por: Junko Kanai, et al.
Publicado: (2021)

Altered nucleocytoplasmic staining patterns of p62/SQSTM1 in cutaneous squamous cell carcinoma precursors
por: Tatsuya Ogawa, et al.
Publicado: (2021)

KEAP1 and epidermal differentiation: Psoriatic epidermis as a model
por: Tatsuya Ogawa, et al.
Publicado: (2021)

Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
por: Yuka Shibata, et al.
Publicado: (2021)

A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection
por: Hiroka Tomiyasu, et al.
Publicado: (2021)

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
por: Levy LL, et al.
Publicado: (2012)

Self-management in patients with psoriasis
por: Pathak SN, et al.
Publicado: (2014)

Lipid profile in psoriasis patients
por: Bhat RM, et al.
Publicado: (2012)

Scale and Pustule on Dermoscopy of Rosacea: A Diagnostic Clue for Demodex Species
por: Gamze Serarslan, et al.
Publicado: (2021)

Role of T-cell-mediated inflammation in psoriasis: pathogenesis and targeted therapy
por: Flatz L, et al.
Publicado: (2013)

Quality of life issues and measurement in patients with psoriasis
por: Tan X, et al.
Publicado: (2012)

Optimal management of nail disease in patients with psoriasis
por: Piraccini BM, et al.
Publicado: (2015)

Efficacy of combination therapy of steroid and methotrexate for refractory pemphigus
por: Miwa Kanaoka, et al.
Publicado: (2021)

Management of guttate psoriasis in patients with associated streptococcal infection
por: Karabudak Abuaf O, et al.
Publicado: (2012)

Improving patient outcomes in psoriasis: strategies to ensure treatment adherence
por: Yélamos O, et al.
Publicado: (2015)

Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability
por: Rogalski C
Publicado: (2015)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
por: Farahnik B, et al.
Publicado: (2016)

The effect of biosimilar administration on clinical outcomes in patients with adalimumab‐controlled psoriasis
por: M. Panahi, et al.
Publicado: (2021)

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
por: Koji Nakajima, et al.
Publicado: (2021)

The management of psoriasis through diet
por: Duarte G, et al.
Publicado: (2012)

Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014)

Psoriasis in pregnancy: challenges and solutions
por: Vena GA, et al.
Publicado: (2015)

Disease burden and patient reported outcomes among patients with moderate to severe psoriasis: an ethnography study
por: Narayanan S, et al.
Publicado: (2014)

Fumaric acid esters in the management of psoriasis
por: Balak DMW
Publicado: (2015)

Biomarkers in the pathogenesis, diagnosis, and treatment of psoriasis
por: Molteni S, et al.
Publicado: (2012)

Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability
por: Manalo IF, et al.
Publicado: (2015)

CD8αα+T cells exert a pro‐inflammatory role in patients with psoriasis
por: Y. Y. Zhang, et al.
Publicado: (2021)